Cargando…
Case Report: Nivolumab-Induced Autoimmune Pancreatitis
Nivolumab is an anti-programmed cell death protein 1 monoclonal antibody. While an effective treatment for a variety of tumors, immune checkpoint inhibitors (ICI) can cause immune-related adverse events such as ICI-pancreatic injury (ICI-PI). Here we present a case of a 60-year-old man with metastat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Innovative Healthcare Institute
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138477/ https://www.ncbi.nlm.nih.gov/pubmed/35665025 http://dx.doi.org/10.36401/JIPO-21-11 |